D-0742-2026 Class II Ongoing

Recalled by Bionpharma Inc. — Princeton, NJ

FDA drug recall D-0742-2026 was initiated by Bionpharma Inc. on Jun 26, 2026 and is designated Class II. Reason for recall: Presence of Foreign Tablets/Capsules The recall status is ongoing.

Recall details

Product Type
Drugs
Report Date
Jul 29, 2026
Initiation Date
Jun 26, 2026
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Divalproex Sodium Delayed-Release Tablets, USP, 500 mg, 500 Tablets bottles, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, Made in India, NDC 69452-435-30.

Reason for recall

Presence of Foreign Tablets/Capsules

Distribution pattern

US Nationwide.

Code information

Lot# 704C003, Exp. 12/31/2028

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0742-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0742-2026. Report a data issue: hello@regdatalab.com.